当前位置: X-MOL 学术Clin. Infect. Dis. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Clinical and Cardiac Safety of Long-term Levofloxacin in Children Treated for Multidrug-resistant Tuberculosis
Clinical Infectious Diseases ( IF 11.8 ) Pub Date : 2018-05-16 , DOI: 10.1093/cid/ciy416
Anthony J Garcia-Prats 1 , Heather R Draper 1 , Heather Finlayson 2 , Jana Winckler 1 , André Burger 3 , Barend Fourie 2 , Stephanie Thee 4 , Anneke C Hesseling 1 , H Simon Schaaf 1
Affiliation  

Safety concerns persist for long-term pediatric fluoroquinolone use. Seventy children (median age, 2.1 years) treated with levofloxacin 10–20 mg/kg once daily for multidrug-resistant tuberculosis (median observation time, 11.8 months) had few musculoskeletal events, no levofloxacin-attributed serious adverse events, and no Fridericia-corrected QT interval >450 ms. Long-term levofloxacin was safe and well tolerated.

中文翻译:

长期左氧氟沙星在儿童耐多药结核病治疗中的临床和心脏安全性

长期使用儿童氟喹诺酮类药物的安全问题仍然存在。70 名儿童(中位年龄,2.1 岁)接受左氧氟沙星 10-20 mg/kg 每日一次治疗耐多药结核病(中位观察时间,11.8 个月)几乎没有肌肉骨骼事件,没有左氧氟沙星引起的严重不良事件,也没有 Fridericia-校正 QT 间期 > 450 ms。长期服用左氧氟沙星是安全且耐受性良好的。
更新日期:2018-05-16
down
wechat
bug